Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.

Japan M&A and Deals (Page 14)

Mergers, tender offers, buyouts and asset sales involving Japanese companies, in English.

  1. Terra Raises Satsudora Buyout Offer to ¥1,260 a Share After Locking In a Quarter of the Register

    Terra raised its take-private offer for Satsudora Holdings from ¥1,220 to ¥1,260 a share after four shareholders holding 24.91% of the drugstore chain signed irrevocable tender pledges, and the board voted again to back the higher price.

  2. Kaga Electronics Lowers the Bar to Keep Its Shinko Shoji Buyout Alive

    Kaga Electronics lowered the minimum acceptance level in its ¥1,580-a-share tender for Shinko Shoji from 66.67% to 55.73% of shares and pushed the deadline to August 3, after Shinko Shoji's stock traded above the offer price.

  3. Japan Hotel REIT Sells an Okinawa Resort at Five Times Book Value to Fund an Osaka Bet

    Japan Hotel REIT is selling The Beach Tower Okinawa for ¥30.9bn, about five times book value, and using the ¥24.1bn gain to buy a fixed-rent Osaka hotel and lift its per-unit distribution 7.8% to ¥5,580.

  4. Kakaku.com Suitor Raises Offer to ¥3,450 to Counter Bain-LY Corporation Bid

    EQT's buyout vehicle for Kakaku.com lifted its tender offer to ¥3,450 a share and pushed the deadline to August 3, betting that Bain Capital and LY Corporation's rival ¥3,500 headline price is unworkable under KDDI's existing non-tender contract.

  5. Medipal Moves to Squeeze Out Remaining PALTAC Shareholders by August 13

    Medipal Holdings' stake in PALTAC has climbed to 97.79% after a completed tender offer, and it is now forcing out the rest of the shareholders at ¥6,650 a share, a move that will end PALTAC's Tokyo Stock Exchange listing next month.

  6. Art Vivant's Controlling Holder Skips Orsay's Tender, But Will Vote to Squeeze Out the Rest

    Katsu Corporation, the holding company tied to Art Vivant founder Katsumi Nozawa, has agreed to keep its 33.76% stake out of Orsay Co.'s buyout tender while promising to vote afterward for a squeeze-out that would leave only Orsay and Katsu Corporation as shareholders.

  7. Seven & i Confirms Talks to Invest in Poland's Largest Convenience Store Chain

    Seven & i Holdings says discussions on a Polish convenience-store investment are real, but nothing has been decided, after media reports the company did not authorize.

  8. Kobe Bussan Buys 13.28% of Makiya, Then Promises Not to Buy More

    Kobe Bussan paid about ¥1.68bn for a 13.28% stake in Makiya to cement a franchise alliance, but it signed a standstill barring further accumulation above the closing-level ratio, plus a lock-up and right of first refusal favoring Makiya.

  9. Toda Kogyo Sells Its Entire Stake in Chinese Pigment Venture for ¥3.48bn

    The Hiroshima chemicals group is handing its 20.7% stake in Zhejiang Huayuan to co-investor Zhejiang Shenghua for roughly ¥3.48bn, freeing money for its mobility, AI and environmental materials push while it keeps buying pigments from the venture it is leaving.

  10. Komehyo pays ¥1.68bn for a loss-making fintech app to speed up its secondhand business

    Japan's biggest reuse retailer is buying Garage Bank, whose cashari app lets users cash out possessions via leaseback instead of selling them, even though the startup lost ¥242.6mn last year on ¥1.05bn of revenue.

  11. Hitotohito Buys Saitama Security Firm SPD for ¥3.16bn, Banks on a Shared Labor Pool

    Hitotohito Holdings is buying Saitama security-staffing firm SPD for ¥3.16bn, funding the whole deal with bank debt that carries covenants tied to the target's own cash flow and net assets from 2028 onward.

  12. LOGOS Holdings to Absorb Distressed Homebuilder Aera Home

    LOGOS Holdings will absorb distressed homebuilder Aera Home into a new subsidiary on Oct. 1, keep its name and its outgoing chief, but the sponsor deal discloses no purchase price.

  13. Daito Pharmaceutical to Merge Kyorin's Generic Drugs Into New Venture, Warns of Unprofitable Parkinson's Pill

    Daito Pharmaceutical is folding into a new joint venture to absorb Kyorin's generic drug business while telling lawmakers that three straight years of annual price cuts have made its dominant Parkinson's disease tablet impossible to produce at a profit.

  14. JR East Doubles Its Stake in Rail Supplier Toyo Denki as Rare-Earth Risk Clouds Outlook

    East Japan Railway is lifting its holding in traction-equipment maker Toyo Denki Seizo to 20% through a ¥1.16bn treasury-share placement, and the supplier is sweetening its dividend even as it guides for a double-digit profit drop next year on China's rare-earth export curbs.

  15. Mitsubishi Corp Completes Texas-Louisiana Shale Gas Buyout, Adds Five New Controlled Units

    Closing the Aethon acquisition on July 14 pushed five entities over the 10% capital threshold that makes them reportable specified subsidiaries, from a $2.2bn Houston holding company to a $142mn Delaware asset-holder.

  16. CyberStep Unwinds Its ¥1.25bn AI Acquisition, Recovers Every Yen

    CyberStep Holdings is returning the AI subsidiary it fully absorbed in January after deciding the ¥1.25bn deal's original business assumptions no longer hold, and the seller is sending back every yen.

  17. Nippon Paint Confirms €7.5bn Proposal for AkzoNobel's Architectural Paint Business

    Nippon Paint says a Bloomberg report on its bid for AkzoNobel's architectural paint unit is accurate at €7.5bn, but insists no acquisition has actually been agreed.

  18. Art Vivant's Founder Raises Buyout Bid to ¥1,900 a Share After First Attempt Flopped

    Katsumi Nozawa's Orsay vehicle is offering ¥1,900 a share for Art Vivant, up from the ¥1,670 that failed to clear its minimum threshold last year, and this time top shareholder Hiroyuki Maki has signed a pledge to tender his full 39.93% stake.

  19. Yoshinoya Pays Partly in Its Own Stock to Buy Majority of Seattle Ramen Chain Kizuki

    Yoshinoya's US subsidiary is paying $28.7m for 70% of Kizuki International, with more than a quarter of that funded by 380,500 newly issued treasury shares rather than cash, plus an earn-out tied to Kizuki's results through 2029.

  20. Daicel and Formosa Plastics Plan a Kaohsiung Chemicals Venture for Taiwan's Chip Boom

    Daicel is committing roughly ¥2bn to a 50-50 joint venture with Formosa Plastics in Kaohsiung to supply Taiwan's semiconductor industry, but Formosa's own board has not yet signed off, and the plant won't start operating until January 2029.

  21. Japan Post Insurance to Hand Legacy Risk to a SCOR-Run Reinsurance Vehicle

    Japan Post Insurance wants to hand decades-old, pre-privatization underwriting risk to a reinsurance vehicle SCOR would build and run, taking a stake capped below half the voting rights, but the companies have signed only a memorandum, not a final deal.

  22. Fujikura Sells Its Entire Stake in a Chinese Optical-Fiber Venture to Partner FiberHome

    Fujikura and its China unit will hand over their full 60% holding in a Wuhan optical-fiber preform venture to co-founder FiberHome Telecommunication for ¥7.97bn and ¥3.99bn, with the deal closing by late September 2026.

  23. Medipal Holdings Pushes PALTAC Stake to 90.84%, Sets Up Full Buyout

    A ¥162.7bn loan-funded tender offer has taken Medipal Holdings' stake in PALTAC past 90%, and the wholesaler now plans to force out remaining shareholders at the same ¥6,650-a-share price.

  24. Arealink to Take Storage-Oh Private at ¥1,340 a Share

    Storage-Oh's board has told shareholders to tender into Arealink's ¥1,340-a-share offer, a 42.25% premium over the pre-announcement price, with major holders already locked in and a squeeze-out ready for anyone who holds out.

Japan M&A and Deals (Page 14) | Tokyo Brief